Kinnate Biopharma Inc

NASDAQ:KNTE   3:59:53 PM EDT
19.90
+1.16 (+6.19%)
Earnings Announcements

Kinnate Biopharma Posts Q3 Loss Per Share Of $24.7

Published: 11/10/2021 22:13 GMT
Kinnate Biopharma Inc (KNTE) - Kinnate Biopharma Inc. Reports Third Quarter 2021 Financial Results.
Kinnate Biopharma Inc - Q3 Net Loss for 2021 Was $24.7 Million, Compared to $10.5 Million for Same Period in 2020.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.57

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.58

More details on our Analysts Page.